drugset / Trial / NCT04199364

Medium vs Low Oxygen Threshold for the Surfactant Administration

NCT04199364

Phase 4 Unknown 200 enrolled Virgilio Paolo Carnielli
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study will be to assess the better fraction inspired oxygen (FiO2) threshold for the surfactant treatment in preterm infants with respiratory distress syndrome (RDS) randomized to receive exogenous surfactant at 25% or 35% of FiO2 threshold. The pulmonary gas-exchanges will be evaluated by oxygen saturation (SpO2) to FiO2 ratio (SFR) and will be used to define the better FiO2 threshold for the surfactant treatment.

Timeline

Start
2021-06-01
Primary completion
2024-07-01
Completion
2025-04-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Poractant alfa Other / unclassified 200 mg/kg Other